HomeLUPIN • NSE
add
Lupin Ltd
Nakaraang pagsara
₹2,092.00
Sakop ng araw
₹2,083.10 - ₹2,105.00
Sakop ng taon
₹1,795.20 - ₹2,402.90
Market cap
957.64B INR
Average na Volume
1.18M
P/E ratio
33.63
Dividend yield
0.57%
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 70.48B | 24.23% |
Gastos sa pagpapatakbo | 34.02B | 18.41% |
Net na kita | 14.78B | 73.34% |
Net profit margin | 20.97 | 39.52% |
Kita sa bawat share | 32.28 | 73.18% |
EBITDA | 21.29B | 56.27% |
Aktuwal na % ng binabayarang buwis | 26.02% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 62.82B | 115.71% |
Kabuuang asset | 335.00B | 31.47% |
Kabuuang sagutin | 137.72B | 41.07% |
Kabuuang equity | 197.28B | — |
Natitirang share | 456.71M | — |
Presyo para makapag-book | 4.87 | — |
Return on assets | — | — |
Return on capital | 18.70% | — |
Cash Flow
Net change in cash
| (INR) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 14.78B | 73.34% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is primarily a manufacturer of generic drugs, covering therapeutic areas such as paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis. Wikipedia
Itinatag
1968
Headquarters
Website
Mga Empleyado
24,006
